GlaxoSmithKline (GSKN) Ownership - Who Owns GlaxoSmithKline?
GlaxoSmithKline (GSKN) Ownership Overview
- 5.87% Mutual Funds
- 0.73% Other Institutional Investors
- 0.35% ETFs
- 93.05% Public Companies and Individual Investors
The ownership structure of GlaxoSmithKline (MX:GSKN) stock is a mix of institutional, retail, and individual investors. Approximately 6.95% of the company’s stock is owned by Institutional Investors, and 93.05% is owned by Public Companies and Individual Investors.
The ownership structure of GlaxoSmithKline (MX:GSKN) stock is a mix of institutional, retail, and individual investors. Approximately 6.95% of the company’s stock is owned by Institutional Investors, and 93.05% is owned by Public Companies and Individual Investors.
Recent Insider Trading Activity
| Date | Name | Activity | Value |
|---|
Recent Hedge Fund Trading Activity
| Date | Firm | Activity | Value |
|---|
Top Shareholders
| Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| John A. Gunn | 48,197,514 | Institution | 2.38% | 2,405,730,714 |
| Dodge & Cox Funds | 39,174,382 | Institution | 1.94% | 1,955,350,103 |
| Ken Fisher | 35,722,792 | Institution | 1.77% | 1,783,067,440 |
| Theofanis Kolokotrones | 25,182,068 | Institution | 1.24% | 1,256,937,742 |
| Vanguard Chester Funds | 18,172,650 | Institution | 0.90% | 907,069,652 |
| Vanguard Wellington Fund | 9,498,942 | Institution | 0.47% | 474,130,191 |
| Fidelity Rutland Square Trust Ii | 8,522,636 | Institution | 0.42% | 425,398,853 |
| Fidelity Hastings Street Trust | 5,642,694 | Institution | 0.28% | 281,649,428 |
| Fidelity Devonshire Trust | 4,136,200 | Institution | 0.20% | 206,454,287 |
| BlackRock, Inc. | 3,620,294 | Institution | 0.18% | 180,703,355 |
Top Mutual Fund Holders
| Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| Dodge & Cox Funds | 39,174,382 | Institution | 1.94% | 1,955,350,103 |
| Vanguard Chester Funds | 18,172,650 | Institution | 0.90% | 907,069,652 |
| Vanguard Wellington Fund | 9,498,942 | Institution | 0.47% | 474,130,191 |
| Fidelity Rutland Square Trust Ii | 8,522,636 | Institution | 0.42% | 425,398,853 |
| Fidelity Hastings Street Trust | 5,642,694 | Institution | 0.28% | 281,649,428 |
| Fidelity Devonshire Trust | 4,136,200 | Institution | 0.20% | 206,454,287 |
| Fidelity Securities Fund | 3,556,375 | Institution | 0.18% | 177,512,902 |
| Vanguard Fenway Funds | 3,549,080 | Institution | 0.18% | 177,148,779 |
| Fidelity Financial Trust | 2,697,200 | Institution | 0.13% | 134,628,041 |
| T. Rowe Price International Funds, Inc. | 2,639,571 | Institution | 0.13% | 131,751,547 |
FAQ
What percentage of GlaxoSmithKline (MX:GSKN) stock is held by institutional investors?
According to the latest TipRanks data, approximately 6.95% of GlaxoSmithKline (MX:GSKN) stock is held by institutional investors: 5.87% by mutual funds, 0.35% by ETFs and 0.73% by other institutional investors.
What percentage of GlaxoSmithKline (MX:GSKN) stock is held by retail investors?
According to the latest TipRanks data, approximately 93.05% of GlaxoSmithKline (MX:GSKN) stock is held by public companies and individual investors.
Who owns the most shares of GlaxoSmithKline (MX:GSKN)?
John A. Gunn owns the most shares of GlaxoSmithKline (MX:GSKN).
What is the significance of the ownership structure for a publicly traded company?
The ownership structure can impact the company's decision making, as large institutional investors may exert influence on the company's management and can also affect the company's stock price with their buying and selling patterns.
